GlassScriptPhysician profile
Amanda Beth Skaggs
NPI 1275517229
$1,304.07
in general payments reported to CMS, 2019-2025
20 companies · $387 in 2025
The $387 reported for 2025 was more than what 81% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $317 · 2023: $209 · 2024: $172 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $203.23 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $193.43 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $168.97 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $167.97 | 2021-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $128.24 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $79.98 | 2021-2025 | |
| Amgen INC. | $77.78 | 2022-2024 | Prolia, Evenity |
| Biogen, INC. | $46.19 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $45.50 | 2021-2023 | Twirla |
| Evofem Biosciences, INC. | $26.90 | 2021-2022 | |
| Avion Pharmaceuticals | $26.30 | 2021-2022 | |
| Molnlycke Health Care US, LLC | $20.46 | 2023 | Mepilex Transfer, Mepilex Lite, Mepilex Ag |
| Boston Scientific Corporation | $17.36 | 2024 | Advantage System |
| Millicent US INC | $16.89 | 2025 | Femlyv |
| Sanofi Pasteur INC. | $16.06 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.27 | 2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $14.49 | 2025 | |
| Therapeuticsmd, INC. | $13.24 | 2021 | |
| Urovant Sciences INC | $13.03 | 2022 | |
| Exeltis, USA INC. | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Skaggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.